Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("
"); });
2021-06-02 HKT 00:38
Share this story
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
HSBC Fined HK$4.2M Over Disclosure Breaches In Research Reports
The Securities and Futures Commission (SFC) has reprimanded and imposed a fine of HK$4.2 million on HSBC for breaching ... Read more
Philippines: The Hidden Fintech Gem You Cant Afford To Miss | Lito Villanueva
The Philippines is the fastest-growing digital economy and home to one of Southeast Asia’s most valuable fintech unic... Read more
SBI And Chainlink Partner On Blockchain And Digital Asset Use
SBI Group, one of Japan’s largest financial conglomerates with assets exceeding the equivalent of US$200 billion, has... Read more
China Considers Yuan-Backed Stablecoins To Advance Global Currency Push
China is considering permitting the use of yuan-backed stablecoins for the first time in a move that could support wide... Read more
Financial Sanctions: LSEG Risk Intelligence Answers Your Key Questions
Financial sanctions are essential government tools for achieving foreign policy objectives – and compliance is mandat... Read more
Korea Development Bank Leads $45M Bridge Round For Upstage
South Korea’s Upstage has secured a US$45 million Series B bridge round supported by Korea Development Bank (KDB), Am... Read more